Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India
[caption id="attachment_9277" align="aligncenter" width="747"] Press Release[/caption]
- Product to strengthen Cipla?s historic leadership in the anti-infectives space in India, and reinforce play in the Indian branded market.
- Acquisition in keeping with Cipla?s legacy of access to life-saving drugs and work in amti-microbial stewardship